The potential impact of our kinetic based approach
Protein misfolding diseases are the most important healthcare challenge of the 21st century and affect 500+ million people costing $2+ trillion per year. As a result of modern lifestyles and increases in life expectancy, this number will triple by 2050.
Join us in pioneering kinetics-based drug discovery
Wren is looking for talented individuals who are as passionate as we are about changing the lives of patients with protein misfolding diseases.